skip to main content

Valproate pregnancy planning — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateCNS TherapeuticsValproate pregnancy planningGPhC CRA

A woman taking valproate has stopped contraception because she may try for pregnancy next year. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Urgently involve the specialist before dispensing or changing therapy

This scenario assesses Valproate pregnancy planning in a UK pharmacy practice context. Valproate is highly teratogenic and requires strict risk minimisation and specialist review. The best answer is Urgently involve the specialist before dispensing or changing therapy because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.

Reference: MHRA Drug Safety Update; BNF